Start Date
March 1, 2019
Primary Completion Date
June 1, 2022
Study Completion Date
September 1, 2022
Phage
The studies will be undertaken using a cocktail of at least 2-3 anti-staphylococcal phages produced by Intralytix Inc, Baltimore, Maryland, USA. The phages will be included in a gel designed for application directly to the wound surface and packaged in 5 ml single use tubes.
University Hospitals Derby and Burton NHS Foundation Trust, Derby
Collaborators (1)
Wellcome Trust
OTHER
BioPhage Theraputics Limited
UNKNOWN
Nottingham University Hospitals NHS Trust
OTHER
University Hospitals of Derby and Burton NHS Foundation Trust
OTHER